- Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid LeukemiaChen, Suning; Zhang, Yanli; Xu, Na; Sun, Hui; Li Weiming; Yang, Yunfan; Zhu, Zunmin; Duan, Minghui; Qian, Sixuan; Zhu, Yu; Luo, Jianmin; Wang, Xiaodong; Yang, Wei; Gu, Weiying; Li, Fei; Liu, Bingcheng; Xu, Yunxiao; Liu, Zhenfang; Wang, Chunling; Jiang, Yirong; Meng, Li; Wen, Qin; Xu, Yanli; Zou, Xingli; Wang, Wei; Xue, Yan; Xu, Hao; Bi, Kehong; Zhou, Fuling; Ma, Liangming; Fu, Rong; Ouyang, Guifang; Ding, Kaiyang; Wu, Depei65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Safety and Efficacy of Flumatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to ImatinibLiu, Yuntao; Yang, Yunfan; Sun, Hui; Meng, Li; Lin, Hai; Chen, Chunyan; Hu, Jianda; Shen, Xuliang; Duan, Minghui; Zhang, Yanli; Abulaiti, Dilinazi; Wang, Jinghua; Zhu, Hongqian; Hua, Luoming; Leng, Qing; Zhang, Chun; Sun, Lili; Li, Weiming; Zhu, Huanling; Liu, Bingcheng; Wang, Jianxiang65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and DasatinibLi Weiming; Zhang, Yanli; Wu, Zhiwei; Wen, Qin; Leng, Qing; Wu, Shuting; Wang, Xiaodong; Chen, Shiming; Yuan, Guolin; Qian, Sixuan; Chen, Suning; Jiang, Daozi; Diao, Lianjun; Xi, Zhenfang; Wu, Hui; Sun, Hui; Yang, Lijie; Wang, Hongjuan; Zhang, Xuefang; Xu, Yanli; Zhao, Xielan; Xu, Na; Meng, Li; Zhu, Zunmin; Zhao, Youfang; Su, Meifang; Yang, Zhuangzhi; Liu, Chuancai; Han, Danlei; Hu, Yu65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
会议论文
Flumatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: An OpenLabel, Multi-Center Study
20阅读
